Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes

Sarao Valentina; Veritti Daniele; Macor Sara; Lanzetta Paolo

首页> 外文期刊>Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie >Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes

【24h】

Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes

机译：玻璃体腔注射贝伐单抗治疗病理性近视引起的脉络膜新生血管：长期结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

To report the long-term results of anti-vascular endothelial growth factor (VEGF) therapy for choroidal neovascularization (CNV) secondary to pathological myopia (PM).

机译：报告抗血管内皮生长因子（VEGF）治疗继发于病理性近视（PM）的脉络膜新生血管（CNV）的长期结果。

著录项

来源
《Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie 》 |2016年第3期| 共10页
作者
Sarao Valentina; Veritti Daniele; Macor Sara; Lanzetta Paolo;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学 ;
关键词
Anti-VEGF; Bevacizumab; Choroidal neovascularization; Intravitreal; Long-term; Pathological myopia;

机译：抗VEGF;贝伐单抗;脉络膜新生血管;玻璃体内;长期;病理性近视;

相似文献

外文文献
中文文献
专利

1. Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes [J] . Sarao Valentina, Veritti Daniele, Macor Sara, Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie . 2016 ,第3期

机译：玻璃体腔注射贝伐单抗治疗病理性近视引起的脉络膜新生血管：长期结果
2. Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization in Japanese patients with pathologic myopia [J] . HayashiK., ShimadaN., MoriyamaM., Retina . 2012 ,第4期

机译：玻璃体腔注射贝伐单抗治疗日本病理性近视患者脉络膜新生血管的两年结果
3. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series. [J] . Iacono P, Parodi MB, Papayannis A, Retina . 2011 ,第9期

机译：玻璃体腔注射贝伐单抗可根据需要用于继发于病理性近视的小凹下脉络膜新生血管：预期病例系列的2年结局。
4. Automatic Detection Of Pathological Myopia And High Myopia On Fundus Images [C] . Siying Dai, Leiting Chen, Ting Lei, IEEE International Conference on Multimedia and Expo . 2020

机译：在眼底图像上自动检测病理性近视和高度近视
5. A Biodegradable Microsphere-Hydrogel Ocular Drug Delivery System for Treatment of Choroidal Neovascularization [D] . Liu, Wenqiang . 2020

机译：一种可生物降解的微球 - 水凝胶眼药递送系统，用于治疗脉络膜新生血管
6. Two-year outcomes of intravitreal bevacizumab for choroidal neovascularization associated with a dome-shaped macula in pathologic myopia [O] . J H Lee, S C Lee, S Choi, 2017

机译：玻璃体腔内贝伐单抗治疗脉络膜新生血管并伴有圆顶状黄斑的病理性近视的两年结局
7. Photodynamic monotherapy or combination treatment with intravitreal triamcinolone acetonide, bevacizumab or ranibizumab for choroidal neovascularization associated with pathological myopia [O] . Rishi, Pukhraj, Rishi, Ekta, Venkataraman, Anusha, 2011

机译：玻璃体腔注射曲安奈德，贝伐单抗或兰尼单抗的光动力单药治疗或联合治疗与病理性近视相关的脉络膜新生血管形成

Intravitreal bevacizumab for choroidal neovascularization due to pathologic myopia: long-term outcomes

摘要

著录项

相似文献

相关主题

期刊订阅